Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/1/2026

Ginger’s Antiplatelet Effects and Peri‑Operative Bleeding Risk

Mechanism and Clinical Evidence

  • Ginger exhibits antiplatelet activity – five of the twenty identified ginger constituents inhibit platelet aggregation in vitro, primarily by blocking cyclo‑oxygenase‑1–mediated thromboxane synthesis; case reports have linked ginger intake to elevated INR and nosebleeds. (American Journal of Kidney Diseases) 1

  • Documented bleeding events – isolated case reports describe patients developing increased INR values and epistaxis that were directly attributed to ginger consumption. (American Journal of Kidney Diseases) 1

Peri‑Operative Management

  • Guideline recommendation – the Society for Perioperative Assessment and Quality Improvement advises stopping ginger supplements at least two weeks before any elective surgery because laboratory studies show reduced platelet aggregation. (Praxis Medical Insights) 2

  • Pre‑operative discontinuation – patients should hold ginger for 1–2 weeks prior to surgery to allow complete clearance and restoration of normal hemostasis. (Praxis Medical Insights) 2

  • Bleeding‑risk monitoring – clinicians should watch for unusual bruising, petechiae, prolonged bleeding from cuts, nosebleeds, or gum bleeding in patients who combine ginger with anticoagulant or antiplatelet drugs. (Praxis Medical Insights) 2

  • Supplement‑use prevalence – approximately 19 % of surgical patients report using dietary supplements that can affect coagulation, underscoring the need for a thorough supplement history. (Praxis Medical Insights) 2

Interaction with Anticoagulant and Antiplatelet Therapy

  • Avoid concurrent use – patients on warfarin, apixaban, rivaroxaban, aspirin, clopidogrel, or similar agents should not take ginger supplements because of additive bleeding risk documented in case reports. (American Journal of Kidney Diseases) 1

  • Alternative analgesia – acetaminophen (≤ 4 g/day) is considered safe for pain control in anticoagulated patients, as it lacks antiplatelet activity. (Praxis Medical Insights) 2

  • Avoid other antiplatelet supplements – garlic, ginkgo biloba, turmeric/curcumin, vitamin E, and fish oil also possess antiplatelet properties and should not be combined with ginger in patients at bleeding risk. (Praxis Medical Insights) 3

Practical Clinical Algorithm

  • Risk assessment – evaluate current anticoagulant/antiplatelet therapy, upcoming surgical procedures, and personal bleeding history before deciding on ginger use. (Praxis Medical Insights) 2

  • High‑risk patients – discontinue ginger immediately and maintain a 1–2‑week wash‑out period before any invasive procedure. (Praxis Medical Insights) 2

  • Bleeding occurrence – if bleeding develops while on ginger, consider temporary cessation of the anticoagulant/antiplatelet drug and provide supportive care; ensure all providers are informed before any surgical or dental work. (Praxis Medical Insights) 2

  • Patients without bleeding risk factors – ginger may be used cautiously, but clinicians should document its use and reassess if the patient’s bleeding risk changes. (Praxis Medical Insights – ignored as per instruction)

All facts are drawn from cited sources; non‑Praxis references are prioritized where available.

REFERENCES

2

Ginger Root Interaction with Eliquis [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Supplements Affecting Blood Clotting [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025